Dissecting Tumor Intrinsic and Immune Drivers of Resistance to Therapy in Non-Small Cell Lung Cancer Damon Runyon - Mark Foundation Physician-Scientist (2020-Present) Natalie Vokes, MD, The University of Texas MD Anderson Cancer Center Read More
Statistical Approaches for Earlier Detection of Cancer Momentum Fellow (2020-2021) Stephen Cristiano, PhD, Johns Hopkins University School of Medicine Read More
Detection and Targeting of Enzymatic Base Editing Deregulation in Leukemia Stem Cells IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Catriona Jamieson, MD, PhD, University of California San Diego Read More
Impact of Clonal Hematopoiesis on the Myeloid Gene Regulatory Networks that Modulate Cancer Evolution and Response to Therapy Momentum Fellow (2020-2022) Pablo Sánchez Vela, MD, Memorial Sloan Kettering Cancer Center Read More
The Cellular and Architectural Determinants of Immune Evasion and Their Impact on Response to Therapy in Classical Hodgkin Lymphoma IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Margaret A. Shipp, MD, Dana-Farber Cancer Institute/ Harvard Medical School Read More
T-Cell Acute Lymphoblastic Leukemia Accumulation in the Central Nervous System IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Susan R. Schwab, PhD, New York University Read More
